Vor Biopharma Inc
Ownership
Ownership Structure
Who owns Vor Biopharma Inc (VOR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 62.9% of the shares are freely tradable; institutional investors hold 83.4%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| TCG Crossover Management, LLC | 9.59 | 5,673,078 | +0.0 | 06/30/2026 |
| FMR Inc | 8.34 | 4,932,149 | +220.3 | 06/30/2026 |
| FCPM III SERVICES BV | 6.96 | 4,117,354 | +0.0 | 06/30/2026 |
| BlackRock Inc | 5.86 | 3,468,107 | +336.4 | 06/30/2026 |
| VR Adviser, LLC | 5.14 | 3,041,719 | +0.0 | 06/30/2026 |
| State Street Corp | 4.42 | 2,616,336 | +133.9 | 06/30/2026 |
| Frazier Life Sciences Management, L.P. | 4.30 | 2,543,939 | +0.0 | 06/30/2026 |
| RA Capital Management, LLC | 4.06 | 2,402,095 | -55.6 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.52 | 2,084,328 | +45.4 | 06/30/2026 |
| Caligan Partners LP | 3.25 | 1,925,066 | +0.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Ra Capital Management, L.p. | 10% Owner | 1,500 | 28,050 $ | Aug 24, 2026 | indirect |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 24, 2026 | Ra Capital Management, L.p. | 10% Owner | Other | 1,500 | 3.74 | 5,604 |
| Apr 22, 2026 | Ra Capital Management, L.P. | Director | Sell | 165,150 | 15.77 | 2,604,416 |
| Apr 20, 2026 | Ra Capital Management, L.P. | Director | Sell | 171,963 | 15.77 | 2,711,857 |
| Apr 17, 2026 | Ra Capital Management, L.P. | Director | Sell | 458,411 | 16.28 | 7,462,931 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.